[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:non-hodgkin-lymphoma:hla-complex":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Non-Hodgkin Lymphoma","HLA Complex",5,[8,16,22,28,35],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05031897","Two Step Haplo With Radiation Conditioning",[12],"Phase 2","RECRUITING","2026-08-26T02:16:32.589113Z","2026-05-05T02:43:29.158573Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05884333","Cord Blood Transplant in Adults With Blood Cancers",[12],"2026-08-26T02:16:44.178623Z","2026-05-05T02:43:27.262377Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06059391","CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant",[12],"2026-08-26T02:16:01.910993Z","2026-05-05T02:35:31.868600Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT07020533","A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant",[32],"Phase 1","2026-08-26T02:18:31.944757Z","2026-05-05T02:43:28.960514Z",{"nct_id":36,"title":37,"phases":38,"status":40,"updated_at":41,"content_modified":42},"NCT05589896","A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies",[39],"Phase 1\u002FPhase 2","ACTIVE_NOT_RECRUITING","2026-08-03T03:35:37.456806Z","2026-05-05T02:43:29.711460Z"]